NIP
NVCR icon

Nicholas Investment Partners’s NovoCure NVCR Stock Holding History

Nicholas Investment Partners’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-68,593
Closed -$7.97M – 208
2021
Q3 		$7.97M Sell
68,593
-16,434
-19% -$2.48M 0.58% 66
2021
Q2 		$18.9M Sell
85,027
-76,110
-47% -$14.8M 1.18% 29
2021
Q1 		$21.3M Buy
161,137
+25,801
+19% +$4.08M 1.48% 12
2020
Q4 		$23.4M Sell
135,336
-64,277
-32% -$8.8M 1.81% 8
2020
Q3 		$22.2M Buy
199,613
+158,817
+389% +$12.7M 2.4% 1
2020
Q2 		$2.42M Sell
40,796
-59,339
-59% -$3.9M 0.49% 78
2020
Q1 		$6.74M Buy
100,135
+14,300
+17% +$1.13M 1.31% 11
2019
Q4 		$7.23M Sell
85,835
-73,879
-46% -$5.96M 0.75% 26
2019
Q3 		$11.9M Buy
159,714
+13,608
+9% +$1.09M 1% 15
2019
Q2 		$9.24M Sell
146,106
-26,211
-15% -$1.33M 0.85% 26
2019
Q1 		$8.3M Sell
172,317
-3,384
-2% -$163K 0.74% 26
2018
Q4 		$5.88M Sell
175,701
-927
-0.5% -$33.9K 0.63% 44
2018
Q3 		$9.26M Buy
176,628
+121,875
+223% +$4.85M 0.74% 30
2018
Q2 		$1.71M Buy
+54,753
New +$1.52M 0.12% 202

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nicholas Investment Partners's NVCR Position: Q4 2021 in Review

Nicholas Investment Partners sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 68,593 shares — an estimated $7.97M sold.

Nicholas Investment Partners first reported a position in NVCR in Q2 2018 and held it in 14 quarters. The position peaked at $23.4M in Q4 2020. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • Nicholas Investment Partners reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • Nicholas Investment Partners sold 68,593 NovoCure shares in Q4 2021, an estimated $7.97M.
  • Nicholas Investment Partners first reported a position in NovoCure in Q2 2018 and held it in 14 quarters.
  • Nicholas Investment Partners's NovoCure position peaked at $23.4M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.